Eintrag weiter verarbeiten
Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy
Gespeichert in:
Zeitschriftentitel: | Haematologica |
---|---|
Personen und Körperschaften: | , , , , , , , , , , , |
In: | Haematologica, 104, 2019, 2, S. e68-e71 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Ferrata Storti Foundation (Haematologica)
|
Schlagwörter: |
author_facet |
Eyre, Toby A. Walter, Harriet S. Iyengar, Sunil Follows, George Cross, Matthew Fox, Christopher P. Hodson, Andrew Coats, Josh Narat, Santosh Morley, Nick Dyer, Martin J.S. Collins, Graham P. Eyre, Toby A. Walter, Harriet S. Iyengar, Sunil Follows, George Cross, Matthew Fox, Christopher P. Hodson, Andrew Coats, Josh Narat, Santosh Morley, Nick Dyer, Martin J.S. Collins, Graham P. |
---|---|
author |
Eyre, Toby A. Walter, Harriet S. Iyengar, Sunil Follows, George Cross, Matthew Fox, Christopher P. Hodson, Andrew Coats, Josh Narat, Santosh Morley, Nick Dyer, Martin J.S. Collins, Graham P. |
spellingShingle |
Eyre, Toby A. Walter, Harriet S. Iyengar, Sunil Follows, George Cross, Matthew Fox, Christopher P. Hodson, Andrew Coats, Josh Narat, Santosh Morley, Nick Dyer, Martin J.S. Collins, Graham P. Haematologica Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy Hematology |
author_sort |
eyre, toby a. |
spelling |
Eyre, Toby A. Walter, Harriet S. Iyengar, Sunil Follows, George Cross, Matthew Fox, Christopher P. Hodson, Andrew Coats, Josh Narat, Santosh Morley, Nick Dyer, Martin J.S. Collins, Graham P. 0390-6078 1592-8721 Ferrata Storti Foundation (Haematologica) Hematology http://dx.doi.org/10.3324/haematol.2018.198812 Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy Haematologica |
doi_str_mv |
10.3324/haematol.2018.198812 |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyNC9oYWVtYXRvbC4yMDE4LjE5ODgxMg |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyNC9oYWVtYXRvbC4yMDE4LjE5ODgxMg |
institution |
DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 |
imprint |
Ferrata Storti Foundation (Haematologica), 2019 |
imprint_str_mv |
Ferrata Storti Foundation (Haematologica), 2019 |
issn |
0390-6078 1592-8721 |
issn_str_mv |
0390-6078 1592-8721 |
language |
English |
mega_collection |
Ferrata Storti Foundation (Haematologica) (CrossRef) |
match_str |
eyre2019efficacyofvenetoclaxmonotherapyinpatientswithrelapsedrefractorymantlecelllymphomaafterbrutontyrosinekinaseinhibitortherapy |
publishDateSort |
2019 |
publisher |
Ferrata Storti Foundation (Haematologica) |
recordtype |
ai |
record_format |
ai |
series |
Haematologica |
source_id |
49 |
title |
Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
title_unstemmed |
Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
title_full |
Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
title_fullStr |
Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
title_full_unstemmed |
Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
title_short |
Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
title_sort |
efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after bruton tyrosine kinase inhibitor therapy |
topic |
Hematology |
url |
http://dx.doi.org/10.3324/haematol.2018.198812 |
publishDate |
2019 |
physical |
e68-e71 |
description |
|
container_issue |
2 |
container_start_page |
0 |
container_title |
Haematologica |
container_volume |
104 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792346321543233536 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T17:37:32.516Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Efficacy+of+venetoclax+monotherapy+in+patients+with+relapsed%2C+refractory+mantle+cell+lymphoma+after+Bruton+tyrosine+kinase+inhibitor+therapy&rft.date=2019-02-01&genre=article&issn=1592-8721&volume=104&issue=2&pages=e68-e71&jtitle=Haematologica&atitle=Efficacy+of+venetoclax+monotherapy+in+patients+with+relapsed%2C+refractory+mantle+cell+lymphoma+after+Bruton+tyrosine+kinase+inhibitor+therapy&aulast=Collins&aufirst=Graham+P.&rft_id=info%3Adoi%2F10.3324%2Fhaematol.2018.198812&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792346321543233536 |
author | Eyre, Toby A., Walter, Harriet S., Iyengar, Sunil, Follows, George, Cross, Matthew, Fox, Christopher P., Hodson, Andrew, Coats, Josh, Narat, Santosh, Morley, Nick, Dyer, Martin J.S., Collins, Graham P. |
author_facet | Eyre, Toby A., Walter, Harriet S., Iyengar, Sunil, Follows, George, Cross, Matthew, Fox, Christopher P., Hodson, Andrew, Coats, Josh, Narat, Santosh, Morley, Nick, Dyer, Martin J.S., Collins, Graham P., Eyre, Toby A., Walter, Harriet S., Iyengar, Sunil, Follows, George, Cross, Matthew, Fox, Christopher P., Hodson, Andrew, Coats, Josh, Narat, Santosh, Morley, Nick, Dyer, Martin J.S., Collins, Graham P. |
author_sort | eyre, toby a. |
container_issue | 2 |
container_start_page | 0 |
container_title | Haematologica |
container_volume | 104 |
description | |
doi_str_mv | 10.3324/haematol.2018.198812 |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzMyNC9oYWVtYXRvbC4yMDE4LjE5ODgxMg |
imprint | Ferrata Storti Foundation (Haematologica), 2019 |
imprint_str_mv | Ferrata Storti Foundation (Haematologica), 2019 |
institution | DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275 |
issn | 0390-6078, 1592-8721 |
issn_str_mv | 0390-6078, 1592-8721 |
language | English |
last_indexed | 2024-03-01T17:37:32.516Z |
match_str | eyre2019efficacyofvenetoclaxmonotherapyinpatientswithrelapsedrefractorymantlecelllymphomaafterbrutontyrosinekinaseinhibitortherapy |
mega_collection | Ferrata Storti Foundation (Haematologica) (CrossRef) |
physical | e68-e71 |
publishDate | 2019 |
publishDateSort | 2019 |
publisher | Ferrata Storti Foundation (Haematologica) |
record_format | ai |
recordtype | ai |
series | Haematologica |
source_id | 49 |
spelling | Eyre, Toby A. Walter, Harriet S. Iyengar, Sunil Follows, George Cross, Matthew Fox, Christopher P. Hodson, Andrew Coats, Josh Narat, Santosh Morley, Nick Dyer, Martin J.S. Collins, Graham P. 0390-6078 1592-8721 Ferrata Storti Foundation (Haematologica) Hematology http://dx.doi.org/10.3324/haematol.2018.198812 Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy Haematologica |
spellingShingle | Eyre, Toby A., Walter, Harriet S., Iyengar, Sunil, Follows, George, Cross, Matthew, Fox, Christopher P., Hodson, Andrew, Coats, Josh, Narat, Santosh, Morley, Nick, Dyer, Martin J.S., Collins, Graham P., Haematologica, Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy, Hematology |
title | Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
title_full | Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
title_fullStr | Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
title_full_unstemmed | Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
title_short | Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
title_sort | efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after bruton tyrosine kinase inhibitor therapy |
title_unstemmed | Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy |
topic | Hematology |
url | http://dx.doi.org/10.3324/haematol.2018.198812 |